Inheritest 500 PLUS Panel Integrated Genetics Westborough LabCorp
United States | 287 | 578 | - D Deletion/duplication analysis
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
Horizon 14 Natera, Inc.
United States | 15 | 15 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 106 plus TSE Natera, Inc.
United States | 103 | 107 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 27 Natera, Inc.
United States | 28 | 28 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 106 Natera, Inc.
United States | 103 | 106 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 27 plus TSE Natera, Inc.
United States | 28 | 29 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 274 Plus TSE Natera, Inc.
United States | 265 | 275 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 274 Natera, Inc.
United States | 265 | 274 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 137 plus TSE Natera, Inc.
United States | 135 | 138 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 137 Natera, Inc.
United States | 135 | 137 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 274 Natera, Inc.
United States | 265 | 274 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 14 plus TSE Natera, Inc.
United States | 15 | 16 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 14 Natera, Inc.
United States | 15 | 15 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon Duchenne Muscular Dystrophy, Cystic Fibrosis and Spinal Muscular Atrophy Natera, Inc.
United States | 4 | 3 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
Horizon Duchenne Muscular Dystrophy, Spinal Muscular Atrophy and Tay Sachs Enzyme Natera, Inc.
United States | 4 | 3 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
Horizon Duchenne Muscular Dystrophy, Cystic Fibrosis, Spinal Muscular Atrophy and Tay Sachs Enzyme Natera, Inc.
United States | 5 | 4 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
Horizon DMD and Spinal Muscular Atrophy Natera, Inc.
United States | 3 | 2 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
Horizon 4 Plus TSE Natera, Inc.
United States | 6 | 5 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 4 Natera, Inc.
United States | 5 | 4 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Cardiomyopathy panel Genome Diagnostics Laboratory University Medical Center Utrecht
Netherlands | 128 | 61 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
